Oxidative stress induced in pathologies: the role of antioxidants.

[1]  J. Eaton,et al.  Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. , 1988, The Journal of clinical investigation.

[2]  R. Verwilghen,et al.  Protective Effect of Vitamin E on Immune Triggered, Granulocyte Mediated Endothelial Injury , 1984, Thrombosis and Haemostasis.

[3]  J. Ward,et al.  Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus. , 1997, The American journal of pathology.

[4]  S. Daniel,et al.  Glutathione‐related enzymes in brain in Parkinson's disease , 1994, Annals of neurology.

[5]  K. Volkovová,et al.  The activity of Cu/Zn-superoxide dismutase and catalase of gastric mucosa in chronic gastritis, and the effect of alpha-tocopherol. , 1994, Bratislavske lekarske listy.

[6]  G. Blyden,et al.  Effect of ciclosporin on rat liver and kidney glutathione content. , 1989, Pharmacology.

[7]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[8]  F. Müller,et al.  Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. , 1992, Free radical biology & medicine.

[9]  L. Smith,et al.  Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. , 1993, The American review of respiratory disease.

[10]  P. Jocelyn.  The standard redox potential of cysteine-cystine from the thiol-disulphide exchange reaction with glutathione and lipoic acid. , 1967, European journal of biochemistry.

[11]  L. Corcos,et al.  A comparison of the effect of inducers on the expression of glutathione‐S‐transferases in the liver of the intact rat and in hepatocytes in primary culture , 1996, Hepatology.

[12]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[13]  P. Palozza.  Prooxidant actions of carotenoids in biologic systems. , 2009, Nutrition reviews.

[14]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[15]  H. Sies,et al.  The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. , 1988, European journal of biochemistry.

[16]  A. Meister,et al.  Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Moolenaar,et al.  Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger (*) , 1995, The Journal of Biological Chemistry.

[18]  R. Stocker,et al.  Assessment of prooxidant activity of vitamin E in human low-density lipoprotein and plasma. , 1999, Methods in enzymology.

[19]  B. Hennig,et al.  Protective effects of vitamin E in age-related endothelial cell injury. , 1989, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[20]  R. Crystal,et al.  Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. , 1993, Thorax.

[21]  B. Kornhuber,et al.  Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. , 1992, Arzneimittel-Forschung.

[22]  N. Hotta,et al.  Lipid peroxide level in plasma of diabetic patients. , 1979, Biochemical medicine.

[23]  D. Baltimore,et al.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.

[24]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[25]  M. Malone,et al.  Glutathione in Health and Disease: Pharmacotherapeutic Issues , 1995, The Annals of pharmacotherapy.

[26]  A. P. Timerman,et al.  Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. , 1991, Chest.

[27]  P. Jenner.  Oxidative damage in neurodegenerative disease , 1994, The Lancet.

[28]  O. Aruoma,et al.  The antioxidant action of taurine, hypotaurine and their metabolic precursors. , 1988, The Biochemical journal.

[29]  L. Tesoriere,et al.  Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes. , 1996, Archives of biochemistry and biophysics.

[30]  R. Ross,et al.  The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.

[31]  L. Packer,et al.  Elucidation of antioxidant activity of dihydrolipoic acid toward hydroxyl radical using a novel hydroxyl radical generator NP-III. , 1995, Biochemistry and molecular biology international.

[32]  B. F. Becker,et al.  Taurine protects the heart from neutrophil-induced reperfusion injury. , 1995, Free radical biology & medicine.

[33]  E. Feskens,et al.  Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke: The Zutphen Study , 1996 .

[34]  J. Bertram,et al.  β-Carotene and canthaxanthin inhibit chemically- and physically- induced neoplastic transformation in 10T1/2 cells , 1988 .

[35]  T. Byers,et al.  Dietary glutathione intake and the risk of oral and pharyngeal cancer. , 1994, American journal of epidemiology.

[36]  S. Archer.  The chemotherapy of schistosomiasis. , 1985, Annual review of pharmacology and toxicology.

[37]  W. Peters,et al.  Effects of dietary anticarcinogens on rat gastrointestinal glutathione peroxidase activity. , 1998, Oncology reports.

[38]  C. Vigo‐Pelfrey.  Membrane Lipid Oxidation , 1990 .

[39]  G. Nabel,et al.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kB , 1989, Nature.

[40]  T. Nicotera,et al.  Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.

[41]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[42]  S. Fortmann,et al.  Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. , 1993, The American journal of clinical nutrition.

[43]  B. Ames,et al.  Ascorbate is an outstanding antioxidant in human blood plasma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Polsky,et al.  Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Virmani,et al.  Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. , 1988, Circulation.

[46]  J. Packer,et al.  Direct observation of a free radical interaction between vitamin E and vitamin C , 1979, Nature.

[47]  E. Harburg,et al.  Glutathione and morbidity in a community-based sample of elderly. , 1994, Journal of clinical epidemiology.

[48]  A. Guillouzo,et al.  Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes. , 1997, Carcinogenesis.

[49]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[50]  D. Janero.  Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. , 1991, Free radical biology & medicine.

[51]  M. Tien,et al.  COMPARATIVE ASPECTS OF SEVERAL MODEL LIPID PEROXIDATION SYSTEMS , 1982 .

[52]  P. Baeuerle,et al.  The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. , 1990, Genes & development.

[53]  T. Charlton,et al.  Chlorination of Tyrosyl Residues in Peptides by Myeloperoxidase and Human Neutrophils (*) , 1995, The Journal of Biological Chemistry.

[54]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Martin J. Stoermer,et al.  Flavones are inhibitors of HIV-1 proteinase. , 1992, Biochemical and biophysical research communications.

[56]  J. Blumberg.  Considerations of the scientific substantiation for antioxidant vitamins and beta-carotene in disease prevention. , 1995, The American journal of clinical nutrition.

[57]  J. Kehrer.  Free radicals as mediators of tissue injury and disease. , 1993, Critical reviews in toxicology.

[58]  L. Tesoriere,et al.  Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo. , 1993, Archives of biochemistry and biophysics.

[59]  A. Holmgren,et al.  Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. , 1992, The Journal of biological chemistry.

[60]  D. Praticò,et al.  Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. , 1992, The Journal of laboratory and clinical medicine.

[61]  S. French,et al.  Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology , 1997, Hepatology.

[62]  V. Natarajan,et al.  Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. , 1995, Journal of lipid research.

[63]  D. Schneider,et al.  Low blood glutathione levels in healthy aging adults. , 1992, The Journal of laboratory and clinical medicine.

[64]  K. Tew,et al.  The antioxidant effects of Crassostrea gigas extract (JCOE) in human volunteers. , 1998, In vivo.

[65]  C. Cross,et al.  Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. , 1996, The American journal of clinical nutrition.

[66]  P. Howdle,et al.  Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation , 1994, Hepatology.

[67]  W. Sessa.  The nitric oxide synthase family of proteins. , 1994, Journal of vascular research.

[68]  B. Fanburg,et al.  Regulation of cellular glutathione. , 1989, The American journal of physiology.

[69]  C. Wanner,et al.  Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. , 1995, Circulation.

[70]  S. Jain,et al.  Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vivo. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[71]  K. Nakachi,et al.  Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases , 1995, BMJ.

[72]  G. Powis,et al.  Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. , 1996, Structure.

[73]  J. Salonen,et al.  Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial. , 1994, European journal of clinical nutrition.

[74]  J. Berliner,et al.  The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.

[75]  B. Ali,et al.  Lipid peroxidation, glutathione and ascorbic acid concentrations in tissues of mice treated with oltipraz: influence of cysteine and olive oil pretreatments. , 1991, General pharmacology.

[76]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[77]  M. Roederer,et al.  Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. , 1992, AIDS research and human retroviruses.

[78]  T. Aw,et al.  Oral glutathione increases tissue glutathione in vivo. , 1991, Chemico-biological interactions.

[79]  C. Rao,et al.  Effect of Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione] on Azoxymethane-Induced Biochemical Changes Related to Early Colon Carcinogenesis in Male F344 Rats , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[80]  A. E. Rogers,et al.  Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. , 1991, Cancer research.

[81]  A. Riccio,et al.  Contribution of vitamin A to the oxidation resistance of human low density lipoproteins. , 1995, Free radical biology & medicine.

[82]  K. Tew,et al.  Increased glutathione expression in cells induced by Crassostera gigas extract (JCOE). , 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[83]  L. Montagnier,et al.  Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases , 1997 .

[84]  Y. Konttinen,et al.  Serum cholesterol and vitamins A and E in juvenile chronic arthritis. , 1990, Clinical and experimental rheumatology.

[85]  D. Breuillé,et al.  Metabolism of cysteine is modified during the acute phase of sepsis in rats. , 1998, The Journal of nutrition.

[86]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[87]  C. Nathan,et al.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[88]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[89]  T. Byers,et al.  Effect of smoking on serum nutrient concentrations in African-American women. , 1994, The American journal of clinical nutrition.

[90]  T. Jávor,et al.  Studies of the blood lipid peroxide status and vitamin E levels in patients with chronic active hepatitis and alcoholic liver disease. , 1986, International journal of clinical pharmacology research.

[91]  H. H. Draper,et al.  A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[92]  八木 国夫.  Lipid peroxides in biology and medicine , 1982 .

[93]  A. Ootsuyama,et al.  Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. , 1986, Carcinogenesis.

[94]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[95]  R. Levine,et al.  Determination of 2-oxohistidine by amino acid analysis. , 1995, Analytical biochemistry.

[96]  M. Silverman,et al.  Bronchoalveolar lavage fluid glutathione in intubated premature infants. , 1993, Archives of disease in childhood.

[97]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[98]  P. L. Vijayammal,et al.  Effect of vitamin A supplementation on cigarette smoke-induced lipid peroxidation. , 1997, Veterinary and human toxicology.

[99]  D. Janero,et al.  Oxidative injury to myocardial membrane: Direct modulation by endogenous α-tocopherol , 1989 .

[100]  Gey Kf.  Inverse correlation of vitamin E and ischemic heart disease. , 1989 .

[101]  G. Rechkemmer,et al.  Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. , 1997, Carcinogenesis.

[102]  R. Floyd.  The role of 8-hydroxyguanine in carcinogenesis. , 1990, Carcinogenesis.

[103]  E. Bartnikowska,et al.  Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[104]  A. Salahudeen,et al.  Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. , 1994, Transplantation.

[105]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[106]  A. Terashi,et al.  Serum Lipid Peroxide Level in Apoplexia , 1986 .

[107]  B. Ames,et al.  Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[108]  U. Förstermann.  Biochemistry and molecular biology of nitric oxide synthases. , 1994, Arzneimittel-Forschung.

[109]  G. Stoner,et al.  Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain a mice. , 1995, Cancer letters.

[110]  M. Hori,et al.  gamma-Glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion. , 1994, Journal of the American College of Cardiology.

[111]  H. Esterbauer,et al.  Biochemical, structural, and functional properties of oxidized low-density lipoprotein. , 1990, Chemical research in toxicology.

[112]  D. Glaise,et al.  Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. , 1997, Carcinogenesis.

[113]  D. Pilbeam.  The Flavonoids: Advances in Research : Edited by J.B. Harborne and T.J. Mabry Chapman and Hall; London, New York, 1982 744 pages. £ 49.50 , 1983 .

[114]  N. Krinsky.  Antioxidant functions of carotenoids. , 1989, Free radical biology & medicine.

[115]  F. Franconi,et al.  Effects of taurine and hypotaurine on lipid peroxidation. , 1995, Biochemical and biophysical research communications.

[116]  A. Bode,et al.  Spontaneous decay of oxidized ascorbic acid (dehydro-L-ascorbic acid) evaluated by high-pressure liquid chromatography. , 1990, Clinical chemistry.

[117]  P. Baeuerle,et al.  NF‐kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. , 1991, The EMBO journal.

[118]  K. Tew,et al.  Impact of dietary supplement of Crassostrea gigas extract (JCOE) on glutathione levels and glutathione S-transferase activity in rat tissues. , 1998, In vivo.

[119]  E. Middleton.  Biological Properties of Plant Flavonoids: An Overview , 1996 .

[120]  N. Kaplowitz,et al.  Glutathione metabolism and its role in hepatotoxicity. , 1991, Pharmacology & therapeutics.

[121]  N. Parinandi,et al.  Peroxidative modification of phospholipids in myocardial membranes. , 1990, Archives of biochemistry and biophysics.

[122]  L. Packer,et al.  Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. , 1994, Biochemical and biophysical research communications.

[123]  F. Marumo,et al.  Significance of plasma glutathione determination in patients with alcoholic and non‐alcoholic liver disease , 1992, Journal of gastroenterology and hepatology.

[124]  T. Aw,et al.  The regulation of hepatic glutathione. , 1985, Annual review of pharmacology and toxicology.

[125]  D. Herold,et al.  Effects of Vitamin E on Susceptibility of Low-Density Lipoprotein and Low-Density Lipoprotein Subfractions to Oxidation and on Protein Glycation in NIDDM , 1995, Diabetes Care.

[126]  K. Chang,et al.  Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats. , 1998, Advances in experimental medicine and biology.

[127]  M. Sunamori,et al.  Salutary effect of reduced glutathione on renal function in coronary artery bypass operation. , 1994, Journal of the American College of Surgeons.

[128]  D. Wood,et al.  Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Men a , 1989, Annals of the New York Academy of Sciences.

[129]  I. Suh,et al.  Serum levels of antioxidant vitamins in relation to coronary artery disease: a case control study of Koreans. , 1996, Biomedical and environmental sciences : BES.

[130]  J. G. Cory,et al.  Ribonucleotide reductase as a site of inhibition of DNA synthesis by the dialdehyde derivatives of purine nucleosides , 1975 .

[131]  C. Del Vecchio Blanco,et al.  Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis. , 1992, Scandinavian journal of clinical and laboratory investigation.

[132]  I. Fridovich,et al.  Vanadate-stimulated oxidation of NAD(P)H. , 1989, Free radical biology & medicine.

[133]  R. Prichard,et al.  Induction of glutathione S-transferase isoenzymes in mouse liver by 5-(2-pyrazynl)-4-methyl-1,2-dithiole-3-thione (oltipraz). , 1992, Biochemical pharmacology.

[134]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.

[135]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .

[136]  L. Packer,et al.  alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.

[137]  K. Oka,et al.  A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of saiboku-to in bronchial asthma. , 1992, Analytical biochemistry.

[138]  L. Graves,et al.  Herbimycin A blocks IL‐1‐induced NF‐κB DNA‐binding activity in lymphoid cell lines , 1992 .

[139]  S. Ansher,et al.  Biochemical effects of dithiolthiones. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[140]  A. Waterhouse.  WINE AND HEART DISEASE , 1995 .

[141]  M. Chung,et al.  An endonuclease activity of Escherichia coli that specifically removes 8-hydroxyguanine residues from DNA. , 1991, Mutation research.

[142]  A. Holmgren,et al.  The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. , 1994, The Journal of biological chemistry.

[143]  R. Kurth,et al.  Inhibition of HIV‐1 replication and NF-x B activity by cysteine and cysteine derivatives , 1991, AIDS.